Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

This non-interventional, descriptive, cross-sectional and multicenter study will examine the treatment of rheumatoid arthritis progressing for less than two years in the Algerian population. Current drug therapy as well as disease status and patient function will be assessed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Rheumatoid arthritis progressing for < 2 years.

Exclusion criteria

Rheumatoid arthritis progressing for < 3 months.
Rheumatoid arthritis onset at < 18 years of age.
Participation in another clinical study.
Rheumatoid arthritis related connective tissue disorder.
Any neuropsychological disorders.

Treatment and study plan

Primary outcomes

Describe medications used in the treatment of rheumatoid arthritis with < 2 years' progression.

Time frame: Single observational visit [Day 1]

Secondary outcomes

Measure disease activity using DAS 28 assessment.

Time frame: Single observational visit [Day 1]
Assess joint damage using the modified SHARP method.

Time frame: Single observational visit [Day 1]
Assess functional status of patients using the Health Assessment Questionnaire (HAQ).

Time frame: Single observational visit [Day 1]

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Case Study of the Treatment of Early Rheumatoid Arthritis in Algerian Patients in Both the Private and Public Healthcare Sectors.

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Dec 11, 2013
Registry last updated: Dec 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed